featured
First-Line Daratumumab, Lenalidomide, and Dexamethasone for Transplant-Ineligible Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: